FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileInvesco Nasdaq Biotechnology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IBBQ
Invesco Nasdaq Biotechnology ETF ETF AnalysisComprehensive ETF analysis for Invesco Nasdaq Biotechnology ETF (IBBQ) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisIBBQ
IBBQ
Invesco Nasdaq Biotechnology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IBBQ
  1. Home
  2. Screener
  3. Invesco Nasdaq Biotechnology ETFIBBQETF

Invesco Nasdaq Biotechnology ETF

ETF
🇺🇸IBBQ•NASDAQ•Equity
Fund size (USD)
$129.71M
Expense Ratio
0.19%
Yield (12 mo)
1.13%
Holdings
246

Your view on IBBQ

Invesco Nasdaq Biotechnology ETF

ETFInvesco
🇺🇸IBBQ•NASDAQ•Equity
Fund size (USD)
$129.71M
Expense Ratio
0.19%
Yield (12 mo)
1.13%
Holdings
246
Your view
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Invesco Nasdaq Biotechnology ETF (IBBQ) is an Equity fund from Invesco, listed since 2021, with $129.7M in assets under management, a 0.19% expense ratio and a NAV of $35.63 USD.

Overview for Invesco Nasdaq Biotechnology ETF

Fund Type
ETF
Fund Issuer
Invesco
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
June 11, 2021
Domicile
US
Website
invesco.com/content/invesco/us/en/financial-products/etfs/invesco-nasdaq-biotechnology-etf.html
Fund Type
ETF
Fund Issuer
Invesco
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
June 11, 2021
Domicile
US
Website
invesco.com/content/invesco/us/en/financial-products/etfs/invesco-nasdaq-biotechnology-etf.html
Fund Type
ETF
Fund Issuer
Invesco
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
June 11, 2021
Domicile
US
Website
invesco.com/content/invesco/us/en/financial-products/etfs/invesco-nasdaq-biotechnology-etf.html

About this fund

The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the N…

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.19%

Yield (12 mo)

1.13%

Fund size

$129.71M

Fund Details

NAV$35.63 USD
Holdings246
Average Volume41.0K
Inception DateJune 11, 2021
Asset ClassEquity
Fund IssuerInvesco
DomicileUS
ISINUS46138G5999
CUSIP46138G599
NAV CurrencyUSD

Expense Ratio

0.19%

Dividend Yield (TTM)

1.13%

Assets Under Management

$129.71M

NAV

$35.63 USD

Holdings

246

Average Volume

41.0K

Inception Date

June 11, 2021

Asset Class

Equity

Fund Issuer

Invesco

Domicile

US

ISIN

US46138G5999

CUSIP

46138G599

NAV Currency

USD

Expense Ratio

0.19%

Dividend Yield (TTM)

1.13%

Assets Under Management

$129.71M

NAV

$35.63 USD

Holdings

246

Average Volume

41.0K

Inception Date

June 11, 2021

Asset Class

Equity

Fund Issuer

Invesco

Domicile

US

ISIN

US46138G5999

CUSIP

46138G599

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 21, 2026Sep 25, 2026$0.2304
Jun 22, 2026Jun 26, 2026$0.0342
Mar 23, 2026Mar 27, 2026$0.0361
Dec 22, 2025Dec 26, 2025$0.0906
Total, 12 months$0.39 a share

Dividend yield (TTM) 1.13% = $0.39 paid per share in the 12 months to Nov 20, 2026 ÷ the $34.48 price. Past distributions; future payments can differ.

Data last updated: Nov 15, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

255 positions
1GILDGilead Sciences Inc
9.41%
2AMGNAmgen Inc
8.44%
3VRTXVertex Pharmaceuticals Inc
7.91%
4REGNRegeneron Pharmaceuticals Inc
6.32%
5MRNAModerna Inc
5.39%
6BIIBBiogen Inc
2.47%
7RVMDRevolution Medicines Inc
2.31%
8INSMInsmed Inc
2.14%
9ILMNIllumina Inc
2.05%
10RPRXRoyalty Pharma PLC
2.04%
11ROIVRoivant Sciences Ltd
1.90%
12ARGNFArgenx SE
1.74%
13UTHRUnited Therapeutics Corp
1.62%
14INCYIncyte Corp
1.59%
15VTRSViatris Inc
1.54%

Concentration

Top 10 Weight48.47%
1GILDGilead Sciences Inc
9.41%
2AMGNAmgen Inc
8.44%
3VRTXVertex Pharmaceuticals Inc
7.91%
4REGNRegeneron Pharmaceuticals Inc
6.32%
5MRNAModerna Inc
5.39%
6BIIBBiogen Inc
2.47%
7RVMDRevolution Medicines Inc
2.31%
8INSMInsmed Inc
2.14%
9ILMNIllumina Inc
2.05%
10RPRXRoyalty Pharma PLC
2.04%
11ROIVRoivant Sciences Ltd
1.90%
12ARGNFArgenx SE
1.74%
13UTHRUnited Therapeutics Corp
1.62%
14INCYIncyte Corp
1.59%
15VTRSViatris Inc
1.54%

Top 10 Weight

48.47%

1GILDGilead Sciences Inc
9.41%$11.68M
2AMGNAmgen Inc
8.44%$10.48M
3VRTXVertex Pharmaceuticals Inc
7.91%$9.81M
4REGNRegeneron Pharmaceuticals Inc
6.32%$7.85M
5MRNAModerna Inc
5.39%$6.69M
6BIIBBiogen Inc
2.47%$3.07M
7RVMDRevolution Medicines Inc
2.31%$2.87M
8INSMInsmed Inc
2.14%$2.65M
9ILMNIllumina Inc
2.05%$2.54M
10RPRXRoyalty Pharma PLC
2.04%$2.53M
11ROIVRoivant Sciences Ltd
1.90%$2.36M
12ARGNFArgenx SE
1.74%$2.16M
13UTHRUnited Therapeutics Corp
1.62%$2.01M
14INCYIncyte Corp
1.59%$1.97M
15VTRSViatris Inc
1.54%$1.92M

Top 10 Weight

48.47%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on19 funds
FundAsset classExpense ratioAssetsHoldings
IBBQInvesco Nasdaq Biotechnology ETFThis fundEquity0.19%$130M246

Comparable funds

  • DVNDTouchstone Dividend Select ETFEquity1.15%$54M44
  • DWMFWisdomTree International Multifactor FundInternational Equity0.38%$33M224
  • ITDEiShares LifePath Target Date 2045 ETFMulti-Asset0.11%$109M12
  • ITDFiShares LifePath Target Date 2050 ETFMulti-Asset0.11%$103M10
  • KNCTInvesco Next Gen Connectivity ETFEquity0.40%$124M101
  • KNOAXS Knowledge Leaders ETFEquity0.75%$43M0
  • PEXLPacer US Export Leaders ETFEquity0.60%$52M102

More Invesco ETFs

  • RZGInvesco S&P SmallCap 600 Pure Growth ETFEquity0.35%$118M126
  • RZVInvesco S&P SmallCap 600 Pure Value ETFEquity0.35%$285M157
  • SATOInvesco Alerian Galaxy Crypto Economy ETFEquity0.66%$6M60
  • SOXQInvesco PHLX Semiconductor ETFEquity0.19%$2.7B31
  • SPGPInvesco S&P 500 GARP ETFEquity0.34%$2.1B75
  • SPHBInvesco S&P 500 High Beta ETFEquity0.25%$782M100
  • SPHDInvesco S&P 500 High Dividend Low Volatility ETFEquity0.30%$3.4B54
  • SPHQInvesco S&P 500 Quality ETFEquity0.20%$18.2B100
  • SPLVInvesco S&P 500 Low Volatility ETFEquity0.25%$7.5B105
  • SPMOInvesco S&P 500 Momentum ETFEquity0.13%$19.5B100
  • SPVMInvesco S&P 500 Value with Momentum ETFEquity0.44%$144M101
  • TANInvesco Solar ETFEquity0.70%$1.1B36
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.